Literature DB >> 24480512

Clival chordoma of the nasal septum secondary to surgical pathway seeding.

J Peyton Hines1, Mary G Ashmead2, Scott P Stringer2.   

Abstract

EDUCATIONAL
OBJECTIVE: At the conclusion of this presentation, the participants should be able to recognize seeding as a form of treatment failure in transseptal resection of clival chordomas.
OBJECTIVES: The purpose is to present a case of implanted metastases in the nasal septum after a transseptal approach for resection of clival chordoma and to compare it with other reported cases in the literature. STUDY
DESIGN: Case report and literature review.
METHODS: The clinical history, radiologic imaging, and pathology of a single patient are reviewed.
RESULTS: A 35-year-old female presented with a left intranasal mass that completely occluded the left nasal passage. The patient had a history of clival chordoma treated at an outside institution with multiple partial resections via a transseptal approach and postoperative Gamma Knife radiotherapy. A 2.5 cm mass in the left nasal cavity as well as a 4 cm sellar mass was identified on MRI. Biopsy of the left nasal mass confirmed the diagnosis of chordoma, which was presumed to be secondary to seeding from a previous resection attempt. The patient received no further treatment due to multiple comorbidities.
CONCLUSIONS: Recurrence of clival chordoma due to seeding along the surgical pathway is an infrequent mechanism of treatment failure, with only rare cases documented in the literature. When deciding on the appropriate surgical approach, the surgeon must consider the risk of septal seeding during a transseptal approach. The emergence of transnasal endoscopic skull base approaches may reduce the likelihood of surgical pathway tumor seeding.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24480512     DOI: 10.1016/j.amjoto.2013.12.018

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  5 in total

1.  Unusual Presentation of Chordoma in Nose.

Authors:  Divya Gupta; Praveen Kumar Rathore; Anju Chauhan; Nita Khurana
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-09-12

2.  Tumour seeding in the surgical pathway after resection of skull base chordoma.

Authors:  Marco Krengli; Arturo Poletti; Eleonora Ferrara; Piero Fossati
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-21

3.  LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas.

Authors:  Cas Vanderheijden; Thomas Vaessen; Youssef Yakkioui; Robert Riedl; Yasin Temel; Koos Hovinga; Govert Hoogland
Journal:  J Neurooncol       Date:  2022-05-04       Impact factor: 4.506

4.  Ectopic Recurrence of Skull Base Chordoma after Proton Therapy.

Authors:  René G C Santegoeds; Mohammed Alahmari; Alida A Postma; Norbert J Liebsch; Damien Charles Weber; Hamid Mammar; Daniëlle B P Eekers; Yasin Temel
Journal:  Curr Oncol       Date:  2022-03-28       Impact factor: 3.109

Review 5.  Metastatic skull base chordoma: A systematic review.

Authors:  Kurtis Young; Torbjoern Nielsen; Hannah Bulosan; Tyler J Thorne; Christian T Ogasawara; Andrew C Birkeland; Dennis M Tang; Arthur W Wu; Toby O Steele
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.